Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Feb 1:41:90.
doi: 10.11604/pamj.2022.41.90.29364. eCollection 2022.

Sublingual misoprostol versus manual vacuum aspiration for treatment of incomplete abortion in Nigeria: a randomized control study

Vincent Chinedu Ani  1 , Joseph Tochukwu Enebe  2 , Cyril Chukwudi Dim  3   4 , Ngozi Regina Dim  5 , Benjamin Chukwuma Ozumba  3
Affiliations
Randomized Controlled Trial

Sublingual misoprostol versus manual vacuum aspiration for treatment of incomplete abortion in Nigeria: a randomized control study

Vincent Chinedu Ani et al. Pan Afr Med J. .

Abstract

Introduction: single-dose of sublingual misoprostol 400mcg with the participant followed-up at the gynecology clinic one week after with an ultrasound scan for the completeness of the uterine evacuation. Objective: to compare the effectiveness of single-dose sublingual misoprostol to manual vacuum aspiration in the treatment of incomplete spontaneous abortion in Enugu, Nigeria.

Methods: the primary outcome measure was the incidence of complete uterine evacuation (complete abortion) after one week of treatment while the secondary outcome measures included incidence, types, and tolerability of treatment side effects as well as participants' satisfaction with the treatment received.

Results: two hundred and three participants who met the study criteria and completed the study were randomised into the intervention group (n=102) received single-dose sublingual misoprostol 400mcg and the control group (n= 101) received manual vacuum aspiration. Incidence of complete abortion was 86.3% for the misoprostol group and 100.0% for the control group, RR = 0.86, (CI 95%: 0.80 - 0.93), p <0.001. The most common side effect was abdominal pain with an incidence of 27.5% versus 48.55 for the misoprostol and control groups respectively (p = 0.002). Most participants in each group (81.1% versus 77.6% for the misoprostol and control groups respectively) considered the side effects as tolerable. The mean visual analogue scale score for maternal satisfaction was higher in the misoprostol group (86.7 ± 14.11) than the control group (81.36 ± 11.10), p < 0.001.

Conclusion: the treatment of incomplete spontaneous abortion with single-dose sublingual misoprostol 400mcg produced a high rate of complete abortion among women in Enugu, Nigeria. Despite having a lower complete abortion rate, maternal satisfaction was higher when compared with women that had manual vacuum aspiration of the uterus. Trial registration: trial registration number - PACTR202009857889210, date of registration - September 23rd, 2020. Retrospectively registered.

Keywords: Sublingual misoprostol; complete abortion; manual vacuum aspiration; post-abortion care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
study flow chart
See this image and copyright information in PMC

References

    1. Lale S, Doris C, Alison G, Özge T, Ann-Beth M, Jane D, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 Jun;2(6):e323–33. - PubMed
    1. American College of Obstetrician and Gynecologists ACOG Committee Opinion No. 427 misoprostol for postabortion care. Obstet Gynecol. 2009 Feb;113(2 Pt 1):465–8. - PubMed
    1. Federal Ministry of Health (FMoH) Integrated maternal newborn and child health strategy. Abuja. 2007.
    1. Greenslade FC, McKay H, Wolf M, McLaurin K. Post-abortion care: a women's health initiative to combat unsafe abortion. Adv Abort Care. 1994;4(1):1–4. - PubMed
    1. Hemlin J, Moller B. Manual vacuum aspiration, a safe and effective alternative in early pregnancy termination. Acta Obstet Gynecol Scand. 2001 Jun;80(6):563–7. - PubMed

Publication types

MeSH terms

Substances